This content is machine translated Tuberculosis in immunosuppression Rare constellation – with very heterogeneous patient clientele When tuberculosis patients are on immunosuppressive therapy and the body’s immune defenses no longer function well, TB usually no longer presents as a local disease but spreads throughout the body.…
View Post 4 min This content is machine translated Tuberculosis New standard for MDR-TB therapy The standard treatment for tuberculosis remains 2 months of quadruple therapy with rifampicin, isoniazid, pyrazinamide, and ethambutol, followed by 4 months of therapy with rifampicin and and isoniazid. The average…
